compound tirzepatide vs semaglutide Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, End Semaglutide vs Tirzepatide - Pro
Description
503A patient-specific
Makary has indicated that the FDA will take an aggressive enforcement stance on GLP-1 compounded products as well as action on misleading advertising
Compared with SGLT2i with insulin, GLP1-ra with insulin was associated with higher risk of diabetic retinopathy (1.205
Muscle loss is common among people taking GLP-1 medications
Presented at #AHA24: In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo
